National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies
Page 14 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.
- Islet Transplantation in Type 1 DiabetesCompletedNCT00434811Phase 3
- Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load MonitoringCompletedNCT00434070
- Accuracy of Hemoglobin A1C to Predict Glycemia in HIVCompletedNCT00433628
- Effects of Anti-HIV Therapy on Nervous System FunctionCompletedNCT00432003
- Clinical IGSP-CHOP BostonCompletedNCT00428831
- China Case Control Avian InfluenzaCompletedNCT00428753
- Prospective Study of AI H5N1 in ChinaCompletedNCT00428493
- Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy AdultsCompletedNCT00428337Phase 1
- Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria VaccineCompletedNCT00427167Phase 1
- Male Circumcision for HIV Prevention in Rakai, UgandaCompletedNCT00425984Phase 3
- Pilot Study of Genotypic AnalysisCompletedNCT00421837
- Inpatient Influenza SurveillanceCompletedNCT00419861
- Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African AdultsWithdrawnNCT00415649Phase 2
- A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case FindingCompletedNCT00414882
- Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for MalariaCompletedNCT00414336Phase 1
- Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African AdultsCompletedNCT00413725Phase 2
- Safety Study of Avian Flu VaccineCompletedNCT00408109Phase 1
- Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and PsoriasisCompletedNCT00407979
- Role of Antimicrobial Peptides in Host Defense Against Vaccinia VirusCompletedNCT00407069
- Immune Response to Varicella Vaccination in Children With Atopic DermatitisCompletedNCT00406081
- Immunity to Human Cholera in BangladeshCompletedNCT00401934
- BCG Vaccination Delivered Intradermally, Orally and by Combined RoutesCompletedNCT00396370Phase 1
- Th1 Response to Influenza: Aging and Vaccine EfficacyTerminatedNCT00396305Phase 4
- Gene Therapy for Chronic Granulomatous DiseaseTerminatedNCT00394316Early Phase 1
- Malaria Transmission and Immunity in Highland KenyaCompletedNCT00393757
- Determining Responses to Two Different Vaccines in HIV and HCV Infected IndividualsCompletedNCT00393276Phase 1
- Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study ParticipantsCompletedNCT00386035
- Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study ParticipantsCompletedNCT00385632
- Proteomic Profiling for Influenza Vaccination - FluMistCompletedNCT00385281Phase 4
- Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected AdultsCompletedNCT00384787Phase 1
- Congenital and Neonatal Malaria in MaliCompletedNCT00384267
- Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in AdultsCompletedNCT00382980Phase 1
- Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)CompletedNCT00380237Phase 1
- B-19 Parvovirus Vaccine StudyTerminatedNCT00379938Phase 1/2
- Prospective Study of Infant DengueStatus unknownNCT00377754
- CS DNA MVA Trial in Mampong, GhanaWithdrawnNCT00377494Phase 1
- ICATA Asthma Mechanistic StudyCompletedNCT00377390
- Collection of Blood Samples From SMART Study Participants for Future Genetic StudiesCompletedNCT00377169
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy AdultsCompletedNCT00375726Phase 1
- Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00375583Phase 2
- Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected LungsWithdrawnNCT00374517Phase 2
- Experimental Vaccine for Prevention of Ebola Virus InfectionCompletedNCT00374309Phase 1
- Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)CompletedNCT00371592Phase 2
- Adenovirus Vaccine for MalariaCompletedNCT00371189Phase 1
- Study of Factors Involved in Resistance to Severe MalariaCompletedNCT00368810
- Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and AdultsCompletedNCT00366782Phase 1
- Enteroaggregative E.Coli (EAEC)TerminatedNCT00362869Phase 1
- Voriconazole Blood Levels and ToxicityCompletedNCT00359541
- Genetic Studies of X-linked Lymphoproliferative DiseaseCompletedNCT00359411
- Genetic Factors in AtherosclerosisCompletedNCT00359307
- Identification of Viruses Associated With Diseases of Unknown CauseTerminatedNCT00359268
- Investigation of Southern Tick-Associated Rash Illness (STARI)TerminatedNCT00358761
- Relationship Between HIV and Malaria in Ugandan ChildrenCompletedNCT00356824
- An Observational Study of Childhood Food AllergyCompletedNCT00356174
- Examining Factors That May Influence Resistance to HIV-1 InfectionCompletedNCT00351442
- Protective Immunity to Human Cholera in BangladeshCompletedNCT00349999
- Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsCompletedNCT00347672Phase 1
- Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered IntramuscularlyCompletedNCT00347555Phase 1
- Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, ChinaCompletedNCT00346762
- Analysis of the Immune Response to the Malaria Parasite in Mali, West AfricaCompletedNCT00346346
- AMA1-C1/Alhydrogel + CpG 7909 for MalariaCompletedNCT00344539Phase 1
- Changes in HIV Viral Load in Patients Undergoing Treatment for FilariasisCompletedNCT00344279
- Surveillance for Leishmaniasis Skin Lesions in MaliCompletedNCT00344084
- Experimental Vaccine for Malaria in Adults in MaliCompletedNCT00343005Phase 1
- New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis PneumoniaCompletedNCT00342589
- Host Response to Infection and Treatment in Lymphatic Filarial Disease in IndiaCompletedNCT00342576
- Collection of Convalescent SARS Plasma by ApheresisCompletedNCT00342524
- Surveillance of Streptococcal Infections in Children in IndiaCompletedNCT00342199
- Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, UgandaCompletedNCT00342160
- Examination of Protective Factors Against Severe MalariaCompletedNCT00342043
- The Effect of Parasitic Worm Infections on the Immune Response to Tuberculosis BacteriaCompletedNCT00342017
- Network on Antimicrobial Resistance in Staphylococcus AureusCompletedNCT00341913
- Epidemiological Study of HIV in the South African National Defense ForceTerminatedNCT00341887
- Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, MaliTerminatedNCT00341783
- Immune Response Regulation in People Infected Concurrently With Malarial and Filarial ParasitesCompletedNCT00341666
- Multi-Drug Resistant Tuberculosis in KoreaCompletedNCT00341601
- Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in AfricaCompletedNCT00341393
- Malaria Vaccine in Children in MaliCompletedNCT00341250Phase 1/2
- Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis ResearchTerminatedNCT00341042
- Severe Malaria and Anti-malarial Drug Resistance in CambodiaCompletedNCT00341003
- Immune Responses to Mycobacterium TuberculosisCompletedNCT00340990
- Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic FilariasisCompletedNCT00340691Phase 2
- Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)CompletedNCT00340574Phase 1
- Experimental Vaccine for Plasmodium Falciparum MalariaCompletedNCT00340431Phase 1
- Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in UgandaCompletedNCT00339456Phase 3
- Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00339417Phase 2
- T and B Cell Response to Avian Flu VaccineCompletedNCT00337896
- Urine Testing to Detect Kidney Transplant RejectionCompletedNCT00337220
- Pharma-Pen (Formerly Innoject) Auto-injectory TIVWithdrawnNCT00335855Phase 1
- Alternative Oseltamivir Dosing StrategiesCompletedNCT00334529Phase 2
- Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in AdultsCompletedNCT00333398Phase 3
- Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected AdultsStatus unknownNCT00331448
- VivaGel™ in Healthy Young WomenCompletedNCT00331032Phase 1
- Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral TherapyCompletedNCT00326482
- CVD 909 Vi Prime Boost StudyCompletedNCT00326443Phase 1
- Immune Responses to Smallpox VaccinationCompletedNCT00325975
- Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood LymphocytesCompletedNCT00324389Phase 2
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy AdultsCompletedNCT00322946Phase 1
- Malaria Prevalence in ChildrenCompletedNCT00322816
- Time to Infection With Malaria ParasitesCompletedNCT00322738
← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas